CV Sciences (CVSI) Other Working Capital Changes (2011 - 2026)
CV Sciences' (CVSI) quarterly Other Working Capital Changes came in at -$12000.0 in Q1 2026, up 80.33% year-on-year from -$6654.5 in Q1 2025, and down 220.0% quarter-over-quarter from $10000.0 in Q4 2025.
CV Sciences (CVSI) Other Working Capital Changes (2011 - 2026) Analysis & Trends
CV Sciences has disclosed Other Working Capital Changes across 16 years of filings, most recently posting -$12000.0 for Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at -$12000.0, up 80.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $187000.0 (up 0.54% YoY), and the FY2025 annual result was $138000.0, down 61.13% from the prior year.
- Other Working Capital Changes came in at -$12000.0 for Q1 2026 at CV Sciences, down from $10000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.4 million in Q2 2023 to a low of -$3.1 million in Q3 2023.
- The 5-year median for Other Working Capital Changes is -$61000.0 (2025), against an average of -$242941.2.
- Across the five-year window, Other Working Capital Changes sank 656.45% in 2022 and soared 817.44% in 2023, its largest moves.
- CV Sciences' Other Working Capital Changes stood at -$197000.0 in 2022, then grew by 22.34% to -$153000.0 in 2023, then surged by 467.97% to $563000.0 in 2024, then plunged by 98.22% to $10000.0 in 2025, then slumped by 220.0% to -$12000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$12000.0 (Q1 2026), $10000.0 (Q4 2025), and $23000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12,000.00 |
| Mar 31, 2026 | -12,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Sep 30, 2025 | 23,000.00 |
| Jun 30, 2025 | 166,000.00 |
| Jun 30, 2025 | 166,000.00 |
| Mar 31, 2025 | -61,000.00 |
| Mar 31, 2025 | -61,000.00 |
| Dec 31, 2024 | 563,000.00 |
| Dec 31, 2024 | 563,000.00 |
| Sep 30, 2024 | -366,000.00 |
| Sep 30, 2024 | -366,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Jun 30, 2024 | 50,000.00 |
| Mar 31, 2024 | 108,000.00 |
| Mar 31, 2024 | 108,000.00 |
| Dec 31, 2023 | -153,000.00 |
| Dec 31, 2023 | -153,000.00 |